JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias
A Nogami, T Kurita, H Abe, K Ando, T Ishikawa… - Circulation …, 2021 - jstage.jst.go.jp
Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …
coverage in Japan in 1974, and its use rapidly became widespread thereafter …
Diretriz brasileira de insuficiência cardíaca crônica e aguda
LEP Rohde, MW Montera, EA Bocchi… - Arq. bras …, 2018 - pesquisa.bvsalud.org
A organização de uma diretriz clínica é tarefa complexa, que necessariamente deve
envolver planejamento prévio, coordenação apropriada, revisão aprofundada da literatura …
envolver planejamento prévio, coordenação apropriada, revisão aprofundada da literatura …
[PDF][PDF] Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda
CCD De Insuficiência, C Colaboradores… - Arq Bras Cardiol, 2018 - SciELO Brasil
A organização de uma diretriz clínica é tarefa complexa, que necessariamente deve
envolver planejamento prévio, coordenação apropriada, revisão aprofundada da literatura …
envolver planejamento prévio, coordenação apropriada, revisão aprofundada da literatura …
Implantable cardiac defibrillators for people with non‐ischaemic cardiomyopathy
Background There is evidence that implantable cardioverter‐defibrillator (ICD) for primary
prevention in people with an ischaemic cardiomyopathy improves survival rate. The …
prevention in people with an ischaemic cardiomyopathy improves survival rate. The …
Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy: An updated meta-analysis and effect on Dutch clinical practice …
DA Theuns, TE Verstraelen, ACJ van der Lingen… - Netherlands Heart …, 2023 - Springer
Background Primary prophylactic implantable cardioverter-defibrillators (ICDs) in patients
with non-ischaemic cardiomyopathy (NICMP) remains controversial. This study sought to …
with non-ischaemic cardiomyopathy (NICMP) remains controversial. This study sought to …
Rationale and study protocol for the BRITISH randomized trial (Using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for …
A Flett, A Cebula, Z Nicholas, R Adam, S Ewings… - American Heart …, 2023 - Elsevier
Background For patients with nonischemic cardiomyopathy (NICM), current guidelines
recommend implantable cardioverter defibrillators (ICD) when left ventricular ejection …
recommend implantable cardioverter defibrillators (ICD) when left ventricular ejection …
Diretriz brasileira de insuficiência cardíaca crônica e aguda
Comitê Coordenador da Diretriz de … - Arquivos Brasileiros …, 2018 - SciELO Brasil
A organização de uma diretriz clínica é tarefa complexa, que necessariamente deve
envolver planejamento prévio, coordenação apropriada, revisão aprofundada da literatura …
envolver planejamento prévio, coordenação apropriada, revisão aprofundada da literatura …
Placebo-controlled, double-blind study of empagliflozin (EMPA) and implantable cardioverter-defibrillator (EMPA-ICD) in patients with type 2 diabetes (T2DM) …
S Fujiki, K Iijima, M Okabe, S Niwano, K Tsujita, S Naito… - Diabetes therapy, 2020 - Springer
Abstract Introduction Type 2 diabetes (T2DM) is associated with cardiovascular death,
including sudden cardiac death due to arrhythmias. Patients with an implantable …
including sudden cardiac death due to arrhythmias. Patients with an implantable …
Use of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in Asia
N Ueda, T Noda, K Kusano, S Yasuda, T Kurita… - JACC: Asia, 2023 - Elsevier
The effectiveness of primary prevention implantable cardioverter-defibrillators (ICDs) is well
established. However, there are several unsolved problems related to ICD use for primary …
established. However, there are several unsolved problems related to ICD use for primary …
Efficacy of pharmacologic and cardiac implantable electronic device therapies in patients with heart failure and reduced ejection fraction: a systematic review and …
Background: The treatment of heart failure with reduced ejection fraction has been the
subject of numerous randomized controlled trials involving medications and cardiac …
subject of numerous randomized controlled trials involving medications and cardiac …